
Katalyst Securities
655 Third Avenue, 18th Floor, New York, NY, 10017, United States
Overview
Katalyst Securities is an independent brokerage firm specializing in private equity investments. The firm provides financial services to a diverse client base of corporations, investment funds, and high net worth individuals. It buys and sells securities such as stocks, bonds, mutual funds, and other investment products.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Violet Defense
Led · Series B · Nov 2021
Violet Defense Group is a Florida-based advanced photonics parent company to Violet Defense (UV disinfection) and Violet Gro (agricultural lighting) that leverages patented technology to improve health and indoor growing. Violet Defense produces pulsed xenon UV disinfection systems the company says can kill up to 99.9% of various pathogens and can be installed full-time in rooms for continuous disinfection. Violet Gro designs patented indoor‑ag lighting that aims to produce more light and less heat, lowering energy costs and improving plant growth. The company plans R&D and product investments including next‑generation Violet Gro lighting and an ag‑tech research facility in partnership with Colorado Mesa University. Violet Defense will launch a third‑generation universal voltage UV disinfection solution and develop a new UV platform called Violet Vision. Violet Defense Group intends to expand internationally via channel and technology partnerships across South America, Europe, Australia, and Asia and will continue building out its senior leadership team to support growth; it completed a $20 million Series B in November 2021 to fund these initiatives. Violet Defense Group, based in Orlando, Florida, is an advanced photonics company that develops patented ultraviolet lighting technology used for germ-killing (Violet Defense) and agricultural lighting (Violet Gro). Its Surface and Air Germ Elimination (S.A.G.E.) devices, which can be deployed mobile or permanently installed, use full-spectrum UV technology that the company says has been shown to kill up to 99.9% of harmful bacteria and viruses, including norovirus, according to the EPA. Products are being used in operating rooms, hotels, schools, ambulances, food-processing facilities, and athletic facilities, and the company has announced collaborations with Siemens and the Orlando Magic plus a distribution partnership with Puro Lighting. Most recently Violet Defense is working with Koch Industries in a design collaboration to address PPE and mask issues associated with the COVID-19 crisis. Demand for its virus-killing UV solutions increased during the COVID-19 pandemic, and the company plans to use proceeds from its Series A to rapidly ramp manufacturing capacity, expand its management team, and invest in next-generation and international products. Violet Defense has now raised more than $10 million in venture funding, with the vast majority provided by Kirenaga Partners, which led the Series A. Violet Defense Group commercializes a patented germ‑killing light technology through its S.A.G.E. (Surface & Air Germ Elimination) UV product line, which deploys pulsed Xenon UV across devices from the Micro to the high‑powered UV Bolt mobile unit. Independent third‑party testing cited in the article shows the technology can kill up to 99.9% of bacteria and viruses, including E. coli, Salmonella, Norovirus, and MRSA. The S.A.G.E. products are designed for continuous, full‑time installation and can operate autonomously or integrate with building automation systems to disinfect unoccupied rooms, targeting markets such as schools, hotels, restaurants, assisted living facilities, and commercial offices. Violet Gro, the company’s recently launched agricultural lighting business, applies the same patented discovery to produce energy‑efficient LED grow lights with a unique lens material and low operating temperatures; the company is researching targeted UV wavelengths to enhance plant responses and control pests and mold. The company plans to use new capital to ramp commercialization across both operating companies and to pursue additional certifications required for international expansion, including into European markets. Financially, the company has raised over $1.8 million in its current $3.0 million round, bringing total investment to date to just over $4.0 million.
Team
No current team members are available.